Clinical Trial Update: Efficacy of Rapamycin Therapy With Chronic Immune Thrombocytopenia

View source ↗

Summary

This document reports on a completed clinical trial evaluating the efficacy of rapamycin therapy in patients with chronic immune thrombocytopenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Rapamycin (sirolimus)

Snippet

Sponsor: First Affiliated Hospital of Suzhou Medical College | Conditions: Immune Thrombocytopenic Purpura | Status: COMPLETED